Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Journal of the American College of Cardiology|September 25, 2012
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)Byeong-Keuk Kim, Myeong-Ki Hong, Dong-Ho Shin, et al.JAMA|November 12, 2015
Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical TrialSung-Jin Hong, Byeong-Keuk Kim, Dong-Ho Shin, et al.Journal of Clinical Medicine|March 17, 2025
Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Patients with Cardiogenic Shock: Results from the Rescue RegistryChewan Lim, Young Hak Chung, Chul-Min Ahn, et al.Clinical Therapeutics|August 25, 2021
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III StudySeung-Ah Lee, Weon Kim, Taek Jong Hong, et al.Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.Scientific Reports|September 19, 2023
Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesionsYonggu Lee, Jeong-Hun Shin, Suk Min Seo, et al.JACC. Cardiovascular Interventions|May 24, 2014
Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitusKyung Woo Park, Joo Myung Lee, Si-Hyuck Kang, et al.Medicine|August 9, 2019
Three-year major clinical outcomes of phosphorylcholine polymer- vs biolinx polymer-zotarolimus-eluting stents: A propensity score matching studyYong Hoon Kim, Ae-Young Her, Seung-Woon Rha, et al.Journal of Geriatric Cardiology : JGC|July 17, 2019
Calcium channel blocker monotherapy versus combination with renin-angiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patientsYong Hoon Kim, Ae-Young Her, Seung-Woon Rha, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 7, 2017
Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT SubstudyByoung-Kwon Lee, Jung-Sun Kim, Oh-Huyn Lee, et al.Pageof 7